Stocks and Investing
Stocks and Investing
Fri, February 5, 2021
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
[ Fri, Feb 05th 2021
] - WOPRAI
Catherine Schulte Maintained (TWST) at Buy with Increased Target to $200 on, Feb 5th, 2021
Catherine Schulte of Baird, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Increased Target from $125 to $200 on, Feb 5th, 2021.
Catherine has made no other calls on TWST in the last 4 months.
There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, all agree with Catherine's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Vijay Kumar of "Evercore ISI Group" Downgraded from Buy to Hold and Increased Target to $140 on, Monday, January 4th, 2021
- Puneet Souda of "SVB Leerink" Maintained at Hold with Increased Target to $100 on, Tuesday, November 24th, 2020
Contributing Sources